Today's focus
1. Aiwei Electronics: Plans to issue shares and pay cash to acquire shares in Yutai Semiconductor. Trading will be suspended from November 10
Aiwei Electronics (688798.SH) announced that the company is planning to purchase shares of Yutai Semiconductor Co., Ltd. and raise supporting capital by issuing shares and paying cash. According to preliminary estimates, it may constitute a major asset restructuring, which will not lead to a change in the actual controller, and will not constitute a restructuring listing; due to uncertainties, the company's stock and convertible bond “Aiwei Convertible Bonds” will be suspended from the opening of the market on November 10, 2026. It is expected that the suspension period will not exceed 10 trading days.
2. Tiger Pharmaceuticals: Selling 64.48% of Fangda Holdings's shares, retaining domestic business and divesting overseas laboratories
Tiger Pharmaceuticals (300347.SZ) announced that the wholly-owned subsidiary Hong Kong Tiger, CRL, and Dr. Li Song's related trusts jointly funded the establishment of SanRex to privatize Fangda Holdings, a holding subsidiary listed in Hong Kong through planning arrangements, and simultaneously implement spin-off: initial transaction price of target business of US$470 million, non-target business outside of China US$804.4 million, non-target business in China US$205.5 million; before the transaction, the company held a total of 64.48% of Fangda Holdings shares. After completion, the privatization stage is possible. The 11.09% of the shares cancelled correspond to a cash consideration of HK$556.7 million (approximately RMB 461.2 million); the profit generated by this transaction is expected to account for more than 50% of the audited net profit for the most recent fiscal year, which is still subject to review by the shareholders' meeting.
3. Tianbang Food: Tongwei Group selected an industrial investor and transferred 1,470 billion yuan of additional shares for 1,441 billion yuan
Tianbang Food (002124.SZ) announced that after a comprehensive assessment by the Investor Review Committee, Tongwei Group Co., Ltd. was determined to be the selected industrial investor and signed the “Reorganization Investment Agreement”, and implemented a capital stock transfer of 13.8 shares for every 10 shares based on the existing total share capital, adding a total of 3,066,268,688 shares. Among them, Tongwei Group conditionally transferred 1,470,120,300 shares, and paid an investment payment of 1,441 billion yuan and a consideration of 0.98 yuan per share; the remaining additional shares were used to settle the bankruptcy claims in China; The hospital has granted an extension of the pre-restructuring period Until May 9, 2027; if the court decides to accept the restructuring, the stock will be subject to a delisting risk warning. There is still a risk that the restructuring fails and the stock listing will be declared bankrupt or the stock listing will be terminated.
4. Baiyunshan: Guangzhou Pharmaceutical was listed and invested, raising no more than 6 billion yuan, and shareholding falling to 53.23%
Baiyunshan (600332.SH) announced that the holding subsidiary Guangzhou Pharmaceutical Co., Ltd. plans to introduce strategic investors and implement targeted stock issuance through public listing on the Guangzhou Property Exchange. The plan is to solicit no more than 15 investors, with an issue price of not less than 3.46 yuan/share, and the targeted issuance of no more than 1,734,104,046 shares; the company does not enjoy priority subscription rights, and is expected to hold no less than 53.23% of the shares and is still the controlling shareholder after the capital increase is completed; the scope of the consolidated statement remains unchanged. There is uncertainty about whether investors will be successfully brought in and the final amount of capital raised.
5. Shengnuo Biotech: Customer returns and refunds of US$24.966 million, which is expected to reduce net profit to mother by RMB 84.2466 million
Shengnuo Biotech (688117.SH) announced that the company and its wholly-owned subsidiary Shengnuo Pharmaceuticals signed a “Return and Refund Agreement” with US customer A, agreeing to return some of the peptide APIs under the customer's two purchase orders of February 6, 2025 and November 24, 2025. The company will refund a total of US$24.9596 million in US dollars; after being refunded according to the agreement, it is expected to reduce its main business revenue of 163.2411 million yuan, total profit of 99.1137 million yuan, and net profit to mother of 84.2466 million yuan, not involving 2026 Accounting data adjustments for the first three quarters and the previous year; the company's revenue for the first three quarters was 741.2052 million yuan, and net profit returned to mother of 170.5896 million yuan.
6. Huaru Technology: Banned from participating in military material engineering service procurement activities within 5 years
Huaru Technology (301302.SZ) announced that the company received the “Prohibited Handling of Beijing Huaru Technology Co., Ltd.” issued by the military procurement network. The processing was an opinion on the suspension on March 31, 2026. The result was that the company was prohibited from participating in military material engineering service procurement activities from November 22, 2023 to November 22, 2028. The scope of entry into force covered the entire military, and the effective categories were all types of projects; the legal representative Han Chao was banned from March 31, 2026 to March 31, 2029. The main violation was” There are other irregularities, according to reports from relevant departments.”
7. Pinwo Foods: The consortium was identified as an investor in the restructuring of Taishan Breweries, or constituted a major asset restructuring
Pinwo Foods (300892.SZ) announced that the consortium formed between the company and Taian Zhiyi Cultural Investment Partnership and Taian Xinyi Cultural Investment Partnership was identified as the restructuring investors of Shandong Taishan Beer Co., Ltd.; Thai Beer Co., Ltd. and four related companies, including Taian Thai Beer Logistics and Foshan Thai Beer, have already decided on the actual merger, bankruptcy and restructuring by the Tai'an Taishan District People's Court on April 23, 2026; there is still a risk that this investment may constitute a major asset restructuring.
Operating performance
1. Daqin Railway: The cargo volume of the Daqin Line in October was 32.2 million tons, a year-on-year decrease of 1.51%
According to the announcement of the Daqin Railway (601006.SH), the average daily traffic volume was 1.032,900 tons, with a cumulative total of 329.59 million tons from January to October, an increase of 3.52% over the previous year.
2. Shennong Group: Sold 428,400 commercial pigs in October, with revenue of 591 million yuan
Shennong Group (605296.SH) announced that sales volume increased 55.90% year on year, revenue increased 49.24% year on year, and average price was 9.83 yuan/kg.
3. Xinwufeng: Sold 384,700 pigs in October, a year-on-year decrease of 36.93%
Xinwufeng (600975.SH) announced that of these, there were 180 million commercial pigs, and the sales price of commercial pigs was 9.69 yuan/kg.
Buyback & increase or decrease holdings
1. Shanghai Electric Power Co., Ltd. plans to repurchase 500 million yuan to 1 billion yuan, and the actual controller simultaneously increases its holdings by 20 million yuan to 30 million yuan
Shanghai Electric Power Co., Ltd. (002463.SZ) announced that the repurchase price was no more than 156.70 yuan/share, and that the Co-production Alliance would increase its holdings within 6 months.
2. Zhongwei Company: First repurchase of 79,600 shares, transaction amount of 19.985,600 yuan
China Micro (688012.SH) announced that the transaction price was 247.51 yuan to 257.00 yuan/share, and the total plan was 400 million yuan to 500 million yuan.
3. Tianci materials: Xu Jinfu, the controlling shareholder and chairman, proposed a repurchase of 50 million yuan to 100 million yuan
Tianci Materials (002709.SZ) announced that the price did not exceed the average price of the previous 30 trading days by 150% for incentives or cancellation.
4. Shengyi Electronics: Shareholder Dongguan Science and Technology Innovation Investment Group plans to increase its holdings by 50 million yuan to 100 million yuan
Shengyi Electronics (688183.SH) announced that before the increase in holdings, the total number of shares held was 7.73%, and that it will be implemented within 6 months.
Sign a big order
1. Traffic Control Technology: Won the bid for the Shuohuang Railway locomotive mobile blockage rehabilitation project, worth 154.2 million yuan
Traffic Control Technology (688015.SH) announced that it has received a notice of winning the bid, has not signed a formal contract, and the delivery period is 90 days.
2. Chongqing Construction Engineering: The consortium won the bid for the Wansheng Economic Development Zone EPC project, with a bid price of about 494 million yuan
Chongqing Construction Engineering (600939.SH) announced that the company is the leader of the consortium, with a construction volume of about 490 million yuan and a construction period of 730 days.